43,326 Shares in Medline $MDLN Bought by Employees Retirement System of Texas

Employees Retirement System of Texas purchased a new position in shares of Medline (NASDAQ:MDLN) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 43,326 shares of the company’s stock, valued at approximately $1,820,000.

A number of other large investors have also recently bought and sold shares of the business. Sound Income Strategies LLC acquired a new stake in Medline during the 4th quarter worth $25,000. Entrust Financial LLC acquired a new stake in Medline during the 4th quarter worth $26,000. NBC Securities Inc. acquired a new stake in Medline during the 4th quarter worth $28,000. Global Retirement Partners LLC acquired a new stake in Medline during the 4th quarter worth $31,000. Finally, North Star Investment Management Corp. acquired a new stake in Medline during the 4th quarter worth $36,000.

Medline Stock Down 0.9%

Shares of MDLN opened at $35.84 on Thursday. The company has a 50-day moving average of $42.52. Medline has a 52-week low of $34.89 and a 52-week high of $50.88.

Medline (NASDAQ:MDLN) last announced its quarterly earnings results on Wednesday, May 6th. The company reported $0.33 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.29 by $0.04. The company had revenue of $7.35 billion during the quarter. The firm’s quarterly revenue was up 10.7% on a year-over-year basis. On average, equities research analysts forecast that Medline will post 1.5 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of equities analysts have commented on MDLN shares. Stifel Nicolaus set a $55.00 price objective on shares of Medline in a research report on Wednesday, February 25th. Sanford C. Bernstein cut their price objective on shares of Medline from $56.00 to $54.00 and set an “outperform” rating for the company in a research report on Thursday, May 7th. Evercore restated an “outperform” rating and set a $55.00 price objective on shares of Medline in a research report on Wednesday, February 25th. Wells Fargo & Company upped their price objective on shares of Medline from $42.00 to $47.00 and gave the stock an “equal weight” rating in a research report on Friday, February 27th. Finally, Leerink Partners set a $56.00 price objective on shares of Medline in a research report on Wednesday, February 25th. Two investment analysts have rated the stock with a Strong Buy rating, twenty-one have assigned a Buy rating, five have issued a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $50.85.

About Medline

Medline (NASDAQ: MDLN) is a healthcare products and services company that manufactures, sources and distributes a wide range of medical supplies and equipment for healthcare providers. Its product portfolio spans clinical consumables and personal protective equipment, surgical and procedural supplies, wound care and incontinence products, diagnostic and laboratory supplies, and select durable medical equipment. Medline supports care settings that include hospitals, health systems, long-term care facilities, ambulatory clinics and home health providers.

In addition to product manufacturing and distribution, Medline provides supply‑chain and logistics services designed to help healthcare customers manage inventory, reduce costs and streamline operations.